Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Pediatr Nephrol. 2019 Jul 20;34(11):2371–2379. doi: 10.1007/s00467-019-04306-7

Table 1.

Demographic and clinical characteristics

Variable N = 412 subjects
N (%) or median (IQR)
Age, years 15.4 (11.9, 18.6)
Male sex 249 (60%)
Race
 Caucasian 282 (68%)
 African American 68 (17%)
 Other 21 (5%)
 More than one excluding African American 23 (6%)
 More than one including African American 18 (4%)
Hispanic 56 (14%)
Povertya
 Yes 93 (23%)
 No 310 (75%)
 Missing 9 (2%)
Maternal education
 High school 161 (39%)
 Some college 110 (27%)
 College and more 129 (31%)
 Missing 12 (3%)
Lead (mcg/dL) 1.2 (0.8, 1.8)
Estimated GFR, mL/min/1.73 m2 39.0 (27.0, 54.3)
CKD Stage
 Stage 1 4 (1%)
 Stage 2 64 (16%)
 Stage 3 213 (52%)
 Stage 4 126 (31%)
 Stage 5 3 (1%)
 Missing 2 (0.5%)
CKD duration, years 13.6 (9.9, 16.5)
Etiology of CKD
 Non-glomerular 344 (84%)
 Glomerular 68 (17%)
Abnormal birth history (premature, small for gestational age, or low-birth weight) 126 (31%)
Hypertension (SBP or DBP ≥ 95th percentile or self-reported hypertension plus antihypertensive use) 175 (42%)
Proteinuria
 None (UPC < 0.2) 113 (27%)
 Significant (UPC 0.2 to < 2) 202 (49%)
 Nephrotic (UPC ≥ 2) 76 (18%)
 Missing 21 (5%)
Hemoglobin, g/dL 12.7(11.5, 13.8)
Anemia (hemoglobin < 5th percentile for age, sex, race)
 No 237 (58%)
 Yes 152 (37%)
 Missing 23 (6%)
a

Based on 2009 poverty guidelines, http://aspe.hhs.gov/poverty/09poverty.shtml

GFR glomerular filtration rate, CKD chronic kidney disease, UPC urine protein to creatinine ratio, mg protein/mg creatinine